Although Pim-1 or Pim-2 can contribute to lymphoid transformation when overexpressed, the physiologic role of these kinases in the immune response is uncertain. We now report that T cells from Pim-1−/−Pim-2−/− animals display an unexpected sensitivity to the immunosuppressant rapamycin. Cytokine-induced Pim-1 and Pim-2 promote the rapamycin-resistant survival of lymphocytes. The endogenous function of the Pim kinases was not restricted to the regulation of cell survival. Like the rapamycin target TOR, the Pim kinases also contribute to the regulation of lymphocyte growth and proliferation. Although rapamycin has a minimal effect on wild-type T cell expansion in vitro and in vivo, it completely suppresses the response of Pim-1−/−Pim-2−/− cells. Thus, endogenous levels of the Pim kinases are required for T cells to mount an immune response in the presence of rapamycin. The existence of a rapamycin-insensitive pathway that regulates T cell growth and survival has important implications for understanding how rapamycin functions as an immunomodulatory drug and for the development of complementary immunotherapeutics.
Skip Nav Destination
Article navigation
17 January 2005
Article|
January 10 2005
The Pim kinases control rapamycin-resistant T cell survival and activation
Casey J. Fox,
Casey J. Fox
Abramson Family Cancer Research Institute and Department of Cancer Biology, University of Pennsylvania, Philadelphia, PA 19104
Search for other works by this author on:
Peter S. Hammerman,
Peter S. Hammerman
Abramson Family Cancer Research Institute and Department of Cancer Biology, University of Pennsylvania, Philadelphia, PA 19104
Search for other works by this author on:
Craig B. Thompson
Craig B. Thompson
Abramson Family Cancer Research Institute and Department of Cancer Biology, University of Pennsylvania, Philadelphia, PA 19104
Search for other works by this author on:
Casey J. Fox
Abramson Family Cancer Research Institute and Department of Cancer Biology, University of Pennsylvania, Philadelphia, PA 19104
Peter S. Hammerman
Abramson Family Cancer Research Institute and Department of Cancer Biology, University of Pennsylvania, Philadelphia, PA 19104
Craig B. Thompson
Abramson Family Cancer Research Institute and Department of Cancer Biology, University of Pennsylvania, Philadelphia, PA 19104
CORRESPONDENCE Craig B. Thompson: [email protected]
Abbreviations used: BrdU, bromo-deoxyuridine; PI, propidium iodide; SOCS, suppressor of cytokine signaling; STAT, signal transducers and activators of transcription; TSST, toxic shock syndrome toxin.
C.J. Fox and P.S. Hammerman contributed equally to this work.
Received:
September 30 2004
Accepted:
December 08 2004
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2005
J Exp Med (2005) 201 (2): 259–266.
Article history
Received:
September 30 2004
Accepted:
December 08 2004
Citation
Casey J. Fox, Peter S. Hammerman, Craig B. Thompson; The Pim kinases control rapamycin-resistant T cell survival and activation . J Exp Med 17 January 2005; 201 (2): 259–266. doi: https://doi.org/10.1084/jem.20042020
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement